0.0248	5.5158	OMIM:614850	#614850 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4;;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 6; IIAE6	TICAM1	148022
0.0248	5.5158	OMIM:613002	#613002 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2;;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 2; IIAE2		
0.0248	4.2318	OMIM:613796	#613796 MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE;;STAT1 DEFICIENCY, AUTOSOMAL RECESSIVE	STAT1	6772
0.0559	5.1752	OMIM:610551	#610551 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1;;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 1; IIAE1	UNC93B1	81622
0.1937	3.1818	OMIM:610163	#610163 IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA	CD247	919
0.2111	3.9589	OMIM:120050	%120050 COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S;;CB3S		
0.2142	2.8838	OMIM:606367	#606367 INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	IL2RA	3559
0.2142	1.9914	OMIM:209000	ATAXIC DIPLEGIA WITH DEFECTIVE CELLULAR IMMUNITY		
0.2545	3.9589	OMIM:600670	VARICELLA, SEVERE RECURRENT		
0.2545	3.9589	OMIM:122460	CORONAVIRUS 229E SUSCEPTIBILITY		
0.2545	2.4094	OMIM:312500	RETICULOENDOTHELIOSIS, X-LINKED		
0.2545	2.1433	OMIM:191150	TUFTSIN DEFICIENCY		
0.2566	3.0520	OMIM:242850	IMMUNE DEFICIENCY DISEASE		
0.2566	2.8808	OMIM:209920	#209920 BARE LYMPHOCYTE SYNDROME, TYPE II;;BLS, TYPE II;;BARE LYMPHOCYTE SYNDROME; BLS;;SEVERE COMBINED IMMUNODEFICIENCY, HLA CLASS II-NEGATIVE;;SCID, HLA CLASS II-NEGATIVEBARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP B, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E, INCLUDED	RFX5, RFXAP, RFXANK, CIITA	5993, 5994, 8625, 4261
0.2566	2.6345	OMIM:614868	#614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITHOR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY	STK4	6789
0.2566	2.4060	OMIM:114580	CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT		
0.2566	2.2542	OMIM:609981	#609981 NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIRDEFECT; NKGCD;;NATURAL KILLER CELL DEFICIENCY, FAMILIAL ISOLATED; NKCD	MCM4	4173
0.2566	2.2272	OMIM:211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1	5205
0.2666	2.6706	OMIM:602347	#602347 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3;;MDR3 DEFICIENCY;;CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, WITH ELEVATED SERUMGAMMA-GLUTAMYLTRANSFERASE	ABCB4	5244
0.2942	2.1954	OMIM:234350	234350 HALOTHANE HEPATITIS		
